Detalles de la búsqueda
1.
[The predictive value of ALT, HBeAg and HBV DNA levels at baseline and the degree of HBV suppression at week 12 adefovir dipivoxil treatment to the efficacy of it at week 52 in patients with HBeAg-positive chronic hepatitis B].
Zhonghua Gan Zang Bing Za Zhi
; 16(5): 341-4, 2008 May.
Artículo
en Zh
| MEDLINE | ID: mdl-18510844
2.
[Clinical investigation of famciclovir in chronic hepatitis B patients irresponsive to alpha interferon treatment].
Zhonghua Gan Zang Bing Za Zhi
; 13(7): 494-6, 2005 Jul.
Artículo
en Zh
| MEDLINE | ID: mdl-16042882
3.
Promoting hepatic growth factor in the treatment of heavy type hepatitis and severe chronic hepatitis: a multicenter clinical study.
Hepatobiliary Pancreat Dis Int
; 3(3): 381-5, 2004 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15313673
4.
[Efficacy and safety in chronic hepatitis B adolescent patients with lamivudine therapy].
Zhonghua Gan Zang Bing Za Zhi
; 12(7): 429-31, 2004 Jul.
Artículo
en Zh
| MEDLINE | ID: mdl-15268810
5.
Bioassay-guided isolation of an alkaloid with antiangiogenic and antitumor activities from the extract of Fissistigma cavaleriei root.
Phytomedicine
; 19(3-4): 301-5, 2012 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22240079
6.
Virologic, serologic, and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-naïve Chinese patients with chronic hepatitis B: a randomized, multicenter study.
Hepatol Int
; 2(4): 486-93, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19669324
7.
Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China.
Hepatol Int
; 1(3): 365-72, 2007 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-19669331
8.
[Specific T cell immune response in chronic hepatitis B patients treated with different doses of recombinant hepatitis B vaccine].
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi
; 21(4): 334-6, 2007 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-18322594
9.
Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China.
Hepatol Int
; 2(1): 136, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19669291
Resultados
1 -
9
de 9
1
Próxima >
>>